Flexbumin FDA Approval History
FDA Approved: Yes (First approved October 17, 2005)
Brand name: Flexbumin
Generic name: albumin human
Dosage form: Solution
Company: Baxter Healthcare Corporation
Treatment for: Plasma Volume Expansion
Flexbumin (albumin human) is the first human serum albumin preparation packaged in a flexible container (previously packaged in glass bottles). Flexbumin is indicated in hypovolemia, hypoalbuminemia due to inadequate reproduction, excessive catabolism, hemorrhage, major surgery or burns, and for use during cardiopulmonary bypass surgery.
Development Timeline for Flexbumin
|Oct 17, 2005||Flexbumin Baxter Healthcare Corporation - Treatment for Plasma Volume Expansion|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.